BSE filing, NSE: TIRUSTA. Summary written from the filing by ALFA Finder's alert engine.
Tirupati Starch & Chemicals Ltd: key numbers
- Share price
- ₹111.50
- Market cap
- ₹106.9 Cr
- Revenue (annual)
- ₹363.3 Cr
- Net profit (annual)
- ₹6.46 Cr
- P/E (TTM)
- 18.8×Sector 26.2×
- Promoter holding
- 72.88%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tirupati Starch & Chemicals Ltd
All →Tirupati Starch & Chemicals Other Announcement
Tirupati Starch & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Tirupati Starch & Chemicals Management Change
Tirupati Starch & Chemicals Limited announced the retirement of Mr. Ramesh Agrawal as Independent Director. His tenure concluded on September 30, 2026, after two consecutive five-year terms.
Tirupati Starch & Chemicals Management Change
Tirupati Starch & Chemicals Ltd announced the re-appointment of Mr. Yogesh Kumar Agrawal, Mr. Ramesh Chandra Goyal, Mr. Yashwant Jain Nandecha, and Mr. Sandeep Agrawal as Directors.
Tirupati Starch & Chemicals Annual General Meeting
Tirupati Starch & Chemicals held its 40th AGM on 21 September 2026, adopting FY26 financials. Directors were re-appointed by rotation and for further terms.
Tirupati Starch & Chemicals Other Announcement
Tirupati Starch & Chemicals informed exchanges about dispatching letters to shareholders with unregistered email addresses, providing instructions to access the FY 2025-26 Annual Report.
Tirupati Starch & Chemicals Annual Report
Tirupati Starch & Chemicals Limited has submitted its 40th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 21, 2026.
Other merger & restructuring announcements
All →Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel transferred 396,000 MVK Industries shares to promoter Gopal Sponge for Rs 4.55 Crore. The sale was completed on October 28, 2026.
- Value
- ₹4.55 Cr
KPIT Technologies Merger & Restructuring Worth ₹19.2 Cr
KPIT Technologies will incorporate a new Vietnam subsidiary for mobility engineering, with 100% control. The company commits USD 2 million (about Rs 19.20 Crore) in cash.
- Value
- ₹19.20 Cr